Skip to main content

Becton Dickinson statistics

  • BDX · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$218.03+1.08%Close 13 Nov 2026 · Market value $59.14B

Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.

Valuation

Becton Dickinson is valued at $59.14B on its latest close. Its price is 62.9 times its earnings.

Market value$59.14B
Enterprise value$75.49B
Price / earnings62.85
Price / sales2.84
Price / book2.42
EV / EBITDA16.93
EV / sales3.62
Price / free cash flow23.59
Price / free cash flow, own 5-year average23.91
EV / EBIT37.51
EV / free cash flow30.01
Free cash flow yield4.2%

Share price

Latest close$218.03
Day's change+1.1%
52-week high$219.78
52-week low$140.11
From 52-week high−0.8%
Return · 1 month+13.7%
Return · 3 months+16.2%
Return · year to date+42.9%
Return · 1 year+44.4%
Beta · 1 year against the S&P 5000.25
50-day average$190.93
200-day average$168.49
RSI 1475.6
Average volume · 20 sessions2.0M

Margins and returns

For fiscal 2025, as filed.

Gross margin45.4%
Operating margin11.8%
Net margin7.7%
Free cash flow margin12.2%
Return on equity6.5%
Return on assets4.1%
Return on invested capital4.7%
Return on invested capital, 5-year average4.5%
Return on capital employed5.4%
Stock-based compensation / revenue1.2%

Financial position

At the end of fiscal 2025.

Cash and equivalents$567.0M
Total debt$20.02B
Net debt$19.44B
Current ratio1.11
Quick ratio0.33
Debt / equity0.79
Net debt / EBITDA3.86
Interest coverage4.21

Growth

Revenue, latest quarter on a year−9.5%
Revenue, twelve months on a year−2.6%
EPS, latest quarter on a year−31.5%
EPS, twelve months on a year−39.2%
Revenue, 5-year compound+6.3%
Revenue, 10-year compound+7.8%
Net income, 5-year compound+13.9%
Free cash flow, 5-year compound+4.3%
EPS, 5-year compound+16.5%

Shares and dividends

For fiscal 2025, as filed.

Diluted shares289M
Shares outstanding, 5-year compound+0.4%
Net share repurchases$1.00B
Dividends per share$4.16
Dividend payout71.3%

Taxes

For fiscal 2025, as filed.

Income tax expense$203.0M
Effective tax rate10.8%

BDX in the terminal

Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.